Offer - Urjas Oil for just ₹ 1 X
Alfaprest T is a prescription medicine that is available as a Drops. Other than this, Alfaprest T has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Alfaprest T. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Common side effects of Alfaprest T include Eye Burning, Eye irritation, Stinging in the Eyes. Besides the aforementioned side effects, there are other adverse effects of Alfaprest T as well, which are listed below. These side effects of Alfaprest T are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Alfaprest T's effect is Mild during pregnancy and Unknown for lactating mothers. It is important to know if Alfaprest T has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Alfaprest T related warnings section.
Individuals suffering from medical conditions like Heart Failure, Diabetes, COPD (Chronic Obstructive Pulmonary Disease) must refrain from the use of Alfaprest T since this can cause severe adverse effects. Other contraindications of Alfaprest T have been discussed in the sections ahead.
Drug reaction of Alfaprest T with other medicines has been reported. A complete list of these interactions is given below.
You should also be aware that Alfaprest T is safe while driving, and is addiction.
Alfaprest T is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Alfaprest T safe for pregnant women?
Alfaprest T has little to no side effects in pregnant women.
Is the use of Alfaprest T safe during breastfeeding?
There is no research available on the side effects of Alfaprest T in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Alfaprest T on the Kidneys?
There can be some harmful effects on your kidneys after taking Alfaprest T. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Alfaprest T on the Liver?
The liver can be affected by Alfaprest T. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Alfaprest T only after medical advice.
What is the effect of Alfaprest T on the Heart?
There may be an adverse effect on the heart after taking Alfaprest T. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Alfaprest T should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Alfaprest T unless your doctor advises you to do so -
Is this Alfaprest T habit forming or addictive?
No, there is no any evidence that Alfaprest T is addictive.
Interaction between Food and Alfaprest T
Taking Alfaprest T with food is safe.
Interaction between Alcohol and Alfaprest T
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Alfaprest T.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Istalol® (timolol maleate ophthalmic solution)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1401
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 153
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1405
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 154
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alphagan® (brimonidine tartrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Simbrinza™ (brinzolamide/brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Enidin® (brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Alphagan® P (brimonidine tartrate)